Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The enzyme heme oxygenase-1 (HO-1) is a cytoprotective and anti-inflammatory protein that degrades heme to produce biliverdin/bilirubin, ferrous iron and carbon monoxide (CO). The anti-inflammatory properties of HO-1 are related to inhibition of adhesion molecule expression and reduction of oxidative stress, while exogenous CO gas treatment decreases the production of inflammatory mediators such as cytokines and nitric oxide (NO). CO-releasing molecules (CO-RMs) are a novel group of substances identified by our group that are capable of modulating physiological functions via the liberation of CO. We aimed in this study to examine the potential anti-inflammatory characteristics of CORM-2 and CORM-3 in an in vitro model of lipopolysaccharide (LPS)-stimulated murine macrophages. Stimulation of RAW264.7 macrophages with LPS resulted in increased expression of inducible NO synthase (iNOS) and production of nitrite. CORM-2 or CORM-3 (10-100 microM) reduced nitrite generation in a concentration-dependent manner but did not affect the protein levels of iNOS. CORM-3 also decreased nitrite levels when added 3 or 6 h after LPS exposure. CORM-2 or CORM-3 did not cause any evident cytotoxicity and produced an increase in HO-1 expression and heme oxygenase activity; this effect was completely prevented by the thiol donor N-acetylcysteine. CORM-3 also considerably reduced the levels of tumor necrosis factor-alpha, another mediator of the inflammatory response. The inhibitory effects of CORM-2 and CORM-3 were not observed when the inactive compounds, which do not release CO, were coincubated with LPS. These results indicate that CO liberated by CORM-2 and CORM-3 significantly suppresses the inflammatory response elicited by LPS in cultured macrophages and suggest that CO carriers can be used as an effective strategy to modulate inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations suggest that NF-κB is activated because of a lack of HO-1 derived anti-inflammatory molecules (CO, bilirubin) and is consistent with previous findings showing that the CO releasing compound, CORM-2, inhibits the DNA binding activity of NF-κB resulting in reduced TNFα production (Sawle et al., 2005; Megias et al., 2007; Motterlini et al., 2012).”
From Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection: Heme oxygenase 1 expression affects Salmonella infection (2016) · cites this paper as Sawle et al., 2005
Citations
Cites
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
Reduced stress defense in heme oxygenase 1-deficient cells
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10925 · Cited by 1,291
Stamler (2001) · doi:10.1016/s0092-8674(01)00495-0 · Cited by 1,261 · cited 2×
“…once CO is liberated, it will tightly bind to cellular targets that preserve CO bioactivity over time, in a manner similar to S-nitrosothiols, such as S-nitrosoalbumin and S-nitrosoglutathione (Stamler et al., 2001), which are long-lived species acting apparently as a reservoir of NO bioactivity.”
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency
Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Ohta, K., Kasahara, Y., & Koizumi, S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4165 · Cited by 1,255
Heme oxygenase-1: unleashing the protective properties of heme
Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
Lee, T.-S., & Chau, L.-Y. (2002) · Nature Medicine · doi:10.1038/nm0302-240 · Cited by 1,019
Carbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998
Heme oxygenase: A novel target for the modulation of inflammatory response
Willis, D., Moore, A. R., Frederick, R., & Willoughby, D. A. (1996) · Nature Medicine · doi:10.1038/nm0196-87 · Cited by 783
Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673
Research works printed but not linked: 1
- 10.1042/bj3480615 · doi:10.1042/bj3480615 · Paper page
Cited by
Items 101–200 of 389
Pentoxifylline attenuation of experimental hepatopulmonary syndrome
Zhang, J., Ling, Y., Tang, L., Luo, B., Chacko, B. K., Patel, R. P., & Fallon, M. B. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01048.2006 · Cited by 74
“Although this is an important area for further investigation, recent work showing that carbon monoxide may inhibit iNOS activity without reducing expression provides one explanation for this finding (14).”
BackgroundWinburn, I. C., Gunatunga, K., McKernan, R., Walker, R. J., Sammut, I. A., & Harrison, J. C. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2012.00856.x · Cited by 86
Zager, R. A., Johnson, A. C. M., Lund, S., & Hanson, S. Y. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2006 · Cited by 73
Renal vascular responses to CORM-A1 in the mouse
RYAN, M., Jernigan, N. L., Drummond, H. A., MCLEMOREJR, G., Rimoldi, J. M., Poreddy, S., Gadepalli, R. S., & Stec, D. E. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.01.012 · Cited by 73
CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury
Jiang, L., Fei, D., Gong, R., Yang, W. P., Yu, W., Pan, S., Zhao, M., & Zhao, M. (2016) · Inflammation Research · doi:10.1007/s00011-016-0973-7 · Cited by 73
“CORM-2 has also been shown to attenuate the inflammatory response in the lung of thermally injured mice [14] and in LPS-stimulated macrophages [15, 16].”
Backgroundη4-Pyrone iron(0)carbonyl complexes as effective CO-releasing molecules (CO-RMs)
Fairlamb, I. J. S., Duhme‐Klair, A., Lynam, J. M., Moulton, B. E., O'Brien, C. T., Sawle, P., Hammad, J., & Motterlini, R. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.085 · Cited by 73
Kim, K.-S., Lee, D., Bae, G., Park, S., Kang, D. G., Lee, H.-S., Oh, H., & Kim, Y. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.026 · Cited by 72
Yoda, Y., Amagase, K., Kato, S., Tokioka, S., Murano, M., Kakimoto, K., Nishio, H., Umegaki, E., Takeuchi, K., & Higuchi, K. (2010) · PubMed · Cited by 75
Bauer, N., Yuan, Z., Yang, X., & Wang, B. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115642 · Cited by 79
Southam, H. M., Williamson, M. P., Chapman, J. A., Lyon, R. L., Trevitt, C. R., Henderson, P. J. F., & Poole, R. K. (2021) · Antioxidants · doi:10.3390/antiox10060915 · Cited by 70
“However, an early study [51] showed that neither CORM-2 nor CORM-3 caused cytotoxicity in an in vitro model of lipopolysaccharide (LPS)-stimulated murine macrophages and produced an increase in HO-1 expression and haem oxygenase activity; this effect was completely prevented by the thiol donor N-acetylcysteine.”
BackgroundStevanin, T. M., Read, R. C., & Poole, R. K. (2007) · Gene · doi:10.1016/j.gene.2007.03.021 · Cited by 75
Cheng, J. G., Zheng, B., Cheng, S., Zhang, G., & Hu, J. (2020) · Chemical Science · doi:10.1039/d0sc00135j · Cited by 69
Sun, B., Sun, Z., Jin, Q., & Chen, X. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.176 · Cited by 74
“CORM-2, a DMSO- soluble CORM, has exhibited anti-inflammatory actions in an in vitro model of LPS-stimulated murine macrophages [33] and renoprotective effects in models of ischemia-reperfusion injury [34] and cisplatin-induced nephrotoxicity [35].”
BackgroundBeneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery
Váradi, J., Lekli, I., Juhász, B., Bácskay, I., Szabo, G., Gesztelyi, R., Szendrei, L., Varga, E., Bak, I., Foresti, R., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.047 · Cited by 69
Park, C. M., Cho, C. W., & Song, Y. S. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.01.019 · Cited by 70
“In this manner, the normal endogenous redox homeostasis is maintained (Sawle et al., 2005).”
BackgroundKim, B.-C., Choi, J.-W., Hong, H.-Y., Lee, S.-N., Hong, S., Park, E., Kim, S., & Lim, C. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.01.009 · Cited by 67
Therapeutic Potential of Heme Oxygenase‐1/Carbon Monoxide in Lung Disease
Constantin, M., Choi, A. J. S., Cloonan, S. M., & Ryter, S. W. (2012) · International Journal of Hypertension · doi:10.1155/2012/859235 · Cited by 76
“For example, CORMs reduce cytokine release in LPS-stimulated macrophages [24] and decrease inflammatory response and oxidative stress in LPS-stimulated endothelial cells [153].”
BackgroundCarbon monoxide in intensive care medicine—time to start the therapeutic application?!
Goebel, U., & Wollborn, J. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-020-0292-8 · Cited by 72
“throughout the literature in different models, including LPS-stimulated macrophages microglia cells [54, 55].”
BackgroundScapens, D., Adams, H., Johnson, T. R., Mann, B. E., Sawle, P., Aqil, R., Perrior, T. R., & Motterlini, R. (2007) · Dalton Transactions · doi:10.1039/b704832g · Cited by 66
The Carbon Monoxide Releasing Molecule CORM-2 Attenuates Pseudomonas aeruginosa Biofilm Formation
Murray, T. S., Okegbe, C., Gao, Y., Kazmierczak, B. I., Motterlini, R., Dietrich, L. E. P., & Bruscia, E. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035499 · Cited by 69
“This compound [Ru(DMSO)4Cl2) consists of a ruthenium metal where the CO groups have been replaced by DMSO [11].”
Sun, B., Zou, X., Chen, Y., Zhang, P., & Shi, G. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.270 · Cited by 69
Chai, J., Luo, L., Hou, F., Fan, X., Yu, J. X., Ma, W., Tang, W., Yang, X., Zhu, J., Kang, W., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163634 · Cited by 70
Vandegriff, K. D., Young, M. A., Lohman, J., Bellelli, A., Samaja, M., Malavalli, A., & Winslow, R. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.219 · Cited by 66
“…actions in models of cardioprotection (Fujimoto et al., 2004; Guo et al., 2004; Stein et al., 2005), vasodilation (Motterlini et al., 2002; Foresti et al., 2004), inflammation (Sawle et al., 2005) and haemorrhage/resuscitation (Otterbein, 2002; Kubulus et al., 2005; Zuckerbraun et al., 2005).”
BackgroundJeong, S., Oh, G., Ha, H.-Y., Koo, B. S., Kim, H. S., Kim, Y., Kim, E.-C., Lee, K.-M., Chung, H., & Pae, H. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.08-194 · Cited by 66
“Heme oxygenase activity assay Heme oxygenase activity was determined at the end of each treatment as described previously [11].”
MethodLee, D., Jang, J., Ko, W., Kim, K.-S., Sohn, J., Kang, M.-S., Ahn, J. C., Kim, Y., & Oh, H. (2013) · Marine Drugs · doi:10.3390/md11041409 · Cited by 71
“The nitrite present in the conditioned medium was determined using a method based on the Griess reaction [39] The level of PGE 2 , TNF-α or IL-1β present in each sample was determined using a commercially available kit from R & D Systems [40].”
MethodInfluentialSoni, H., Pandya, G. M., Patel, P., Acharya, A., Jain, M. R., & Mehta, A. A. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.013 · Cited by 69
“Indeed, an earlier study by Sawle et al. (2005) demonstrated the ability of CORM-2 (50 and 100 μM) to induce HO-1 protein expression and activity in murine RAW264.”
BackgroundLee, D., Jeong, G., Li, B., Park, H., & Kim, Y. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.04.019 · Cited by 64
Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide
Bannenberg, G. L., & Vieira, H. L. A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902858824 · Cited by 62
“The administration of sulfide also lowers pro-inflammatory cytokine release in a murine LPS-stimulated peritonitis model.”
BackgroundInfluentialTsoyi, K., Nizamutdinova, I. T., Jang, H. J., Mun, L., Kim, H. J., Seo, H. G., Lee, J. H., & Chang, K. C. (2010) · Shock · doi:10.1097/shk.0b013e3181e46f15 · Cited by 63
Carbon monoxide and the eye: Implications for glaucoma therapy
Bucolo, C., & Drago, F. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.013 · Cited by 65
“We believe that the early pharmacological effect of the drug is due to the rapid availability of CO in the ocular tissue, and the late effect is explained by CORM-3 inducing an increase in HO-1 expression (Sawle et al., 2005).”
Mitterstiller, A.-M., Haschka, D., Dichtl, S., Nairz, M., Demetz, E., Talasz, H., Soares, M. P., Einwallner, E., Esterbauer, H., Fang, F. C., et al. (2016) · Cellular Microbiology · doi:10.1111/cmi.12578 · Cited by 62
“These observations suggest that NF-κB is activated because of a lack of HO-1 derived anti-inflammatory molecules (CO, bilirubin) and is consistent with previous findings showing that the CO releasing compound, CORM-2, inhibits the DNA binding activity of NF-κB resulting in reduced TNFα production (Sawle et al., 2005;…”
Medicinal Organometallic Chemistry
Jaouen, G., & Dyson, P. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045047-4/00173-4 · Cited by 62
Carbon monoxide: An unusual drug
Gullotta, F., di Masi, A., & Ascenzi, P. (2012) · IUBMB Life · doi:10.1002/iub.1015 · Cited by 72
Therapeutic potential of carbon monoxide in multiple sclerosis
Fagone, P., Mangano, K., Coco, M., Perciavalle, V., Garotta, G., Romão, C. C., & Nicoletti, F. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04491.x · Cited by 67
Wilson, J. L., Jesse, H. E., Hughes, B., Lund, V. A., Naylor, K. L., Davidge, K. S., Cook, G. M., Mann, B. E., & Poole, R. K. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4784 · Cited by 66
“Both these compounds are imperfect controls: RuCl2(DMSO)4 lacks the glycinate group of CORM-3, and iCORM has not been exposed to biological species that induce release of more CO than can be achieved by gassing.”
BackgroundInfluentialMinegishi, S., Yumura, A., Miyoshi, H., Negi, S., Taketani, S., Motterlini, R., Foresti, R., Kano, K., & Kitagishi, H. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02229 · Cited by 63
Antithrombotic Properties of Water-Soluble Carbon Monoxide-Releasing Molecules
Kramkowski, K., Leszczynska, A., Mogielnicki, A., Chłopicki, S., Fedorowicz, A., Grochal, E., Mann, B. E., Brzóska, T., Urano, T., Motterlini, R., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.253989 · Cited by 63
“iCORMA1 was prepared by slight acidification of the solution with HCl, then rebuffering and bubbling with N 2 .(24,28) Pentobarbital (Vetbutal, Biovet, Pulawy, Poland; or Nembutal, Dainippon Pharmaceutical, Osaka, Japan), PBS (Biomed, Lublin, Poland), Tris buffer (Sigma-Aldrich, Hamburg, Germany), collagen (Chrono-Log…”
MethodJeon, W.-K., Hong, H.-Y., & Kim, B.-C. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.05.016 · Cited by 60
Qureshi, O. S., Zeb, A., Akram, M., Kim, M.-S., Kang, J.-H., Kim, H.-S., Majid, A., Han, I., Chang, S., Bae, O., et al. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.09.008 · Cited by 64
Lipid Autacoids in Inflammation and Injury Responses: A Matter of Privilege
Gronert, K. (2008) · Molecular Interventions · doi:10.1124/mi.8.1.7 · Cited by 60
Desmard, M., Boczkowski, J., Poderoso, J., & Motterlini, R. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1803 · Cited by 59
“…(26, 145); prevention of cardiac graft rejection and positive inotropic effects on the heart (26); suppression of the inflammatory response (10, 133); inhibition of platelet aggregation (23); attenuation of endotoxin-mediated vascular dysfunction (46); and improved kidney function after…”
Nrf2 is essential for the anti-inflammatory effect of carbon monoxide in LPS-induced inflammation
Qin, S., Du, R., Yin, S., Liu, X., Xu, G., & Cao, W. (2015) · Inflammation Research · doi:10.1007/s00011-015-0834-9 · Cited by 62
“Many studies reported that CO-releasing molecules suppressed LPS-stimulated inflammatory response and played a beneficial role similar to that of CO gas, both in vitro and in animal models of various inflammatory diseases [21, 22].”
Musameh, M. D., Green, C. J., Mann, B. E., Fuller, B. J., & Motterlini, R. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.08.005 · Cited by 66
Mizuguchi, S., Stephen, J., Bihari, R., Markovic, N., Suehiro, S., Capretta, A. A., Potter, R. F., & Cepinskas, G. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00305.2009 · Cited by 68
“In addition, the anti-inflammatory activity of CORM-2, a DMSO-soluble CORM, has also been demonstrated in experimental models of sepsis in vivo (CLP-induced peritonitis) (5) and in vitro (LPS-stimulated murine macrophages) (41).”
BackgroundHewett, P. W., Fujisawa, T., Sissaoui, S., Cai, M., Gueron, G., Al‐Ani, B., Cudmore, M., Ahmed, F. S., Wong, M. K. K., Wegiel, B., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-01-0002 · Cited by 55
Schallner, N., Romão, C. C., Biermann, J., Lagrèze, W. A., Otterbein, L. E., Buerkle, H., Loop, T., & Goebel, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060672 · Cited by 62
“The role of these ‘‘primary targets’’ in mediating anti-inflammatory [11], anti-proliferative [12] and vasoactive [13] effects of CORMs have been characterized in non-neuronal systems, but not in neuronal systems.”
BackgroundChłopicki, S., Łomnicka, M., Fedorowicz, A., Grochal, E., Kramkowski, K., Mogielnicki, A., Buczko, W., & Motterlini, R. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0732-4 · Cited by 54
“2003), and inhibition of the inflammatory response (Sawle et al. 2005).”
InfluentialSun, B., Sun, H., Liu, C., Shen, J., Chen, Z., & Chen, X. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2006.08.032 · Cited by 55
Guillén, M. I., Megías, J., Clérigues, V., Gomar, F., & Alcaraz, M. J. (2008) · Rheumatology · doi:10.1093/rheumatology/ken264 · Cited by 54
Wilson, J. L., Fayad‐Kobeissi, S., Oudir, S., Haas, B., Michel, B. W., Dubois‐Randé, J., Ollivier, A., Martens, T., Rivard, M., Motterlini, R., et al. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201403901 · Cited by 53
CO and CO ‐releasing molecules ( CO ‐ RMs ) in acute gastrointestinal inflammation
Babu, D., Motterlini, R., & Lefebvre, R. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12632 · Cited by 57
“In LPS-stimulated macrophages, CO decreased nitrite (marker of NO production) levels without changing iNOS protein expression (Sawle et al., 2005), suggesting that CO might inhibit iNOS activity.”
BackgroundInfluentialEffects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats
Chen, P., Sun, B., Chen, H., Wang, G., Pan, S., Kong, R., Bai, X., & Wang, S. (2009) · Cytokine · doi:10.1016/j.cyto.2009.09.013 · Cited by 54
Şener, A., Tran, K.-C., Deng, J. P., Garcia, B. M., Lan, Z., Liu, W., Sun, T., Arp, J., Salna, M. P., Acott, P., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.12.020 · Cited by 53
Ren, S., Xu, Y., Dong, X., Mu, Q., Chen, X., Yu, Y., & Su, G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02670-7 · Cited by 68
“Intriguingly, CO deactivates inducible NO synthase (iNOS) by binding to the iron center of the heme, and thus selectively depletes NO [181].”
BackgroundLong, R., Salouage, I., Berdeaux, A., Motterlini, R., & Morin, D. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.10.002 · Cited by 51
Gomperts, E. D., Belcher, J. D., Otterbein, L. E., Coates, T. D., Wood, J. C., Skolnick, B. E., Levy, H. A., & Vercellotti, G. M. (2017) · American Journal of Hematology · doi:10.1002/ajh.24750 · Cited by 56
Negi, G., Nakkina, V., Kamble, P., & Sharma, S. S. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.014 · Cited by 55
Structure−Activity Relationships of Methoxychalcones as Inducers of Heme Oxygenase-1
Sawle, P., Moulton, B. E., Jarzykowska, M., Green, C. J., Foresti, R., Fairlamb, I. J. S., & Motterlini, R. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800115g · Cited by 50
Heme oxygenase-1: a molecular brake on hepatocellular carcinoma cell migration
Zou, C., Zhang, H., Li, Q., Xiao, H., Yu, L., Shi, K., Zhou, L., Liu, W., Wang, W., Huang, H., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr225 · Cited by 55
Deng, R., Wang, S.-M., Yin, T., Ye, T., Shen, G., Li, L., Zhao, J., Sang, Y., Duan, X.-G., & Wei, Y. (2012) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13715991125684 · Cited by 53
Schwer, C. I., Mutschler, M., Stoll, P., Goebel, U., Humar, M., Hoetzel, A., & Schmidt, R. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.059519 · Cited by 48
“However, inconsistent data exist about the ability of CORM-2 to up-regulate HO-1 (Sawle et al., 2005; Taille et al., 2005; Sun et al., 2008).”
BackgroundLin, C., Yang, C.-C., Hsiao, L., Chen, S.-Y., & Yang, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00387 · Cited by 50
“Furthermore, CORM-3 has a wide range of functions that produce anti-inflammatory and anti-oxidant effects to reduce nitrite and tumor necrosis factor-α release from BV-2 microglia cells (Bani-Hani et al., 2006) and murine macrophages (Sawle et al., 2005).”
BackgroundPrevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole
Higuchi, K., Yoda, Y., Amagase, K., Kato, S., Tokioka, S., Murano, M., Takeuchi, K., & Umegaki, E. (2009) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.sr09-58 · Cited by 51
“In a recent study, CO released by CORM-2 was reported to inhibit NO and TNF-α production in mice [46, 47].”
Li, Q., Ye-sen, Z., Jiang, H., Xu, H., & Sun, Y. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.19 · Cited by 47
Recent Advances on Carbon Monoxide Releasing Molecules for Antibacterial Applications
Cheng, J., & Hu, J. (2021) · ChemMedChem · doi:10.1002/cmdc.202100555 · Cited by 46
Wound healing activity of carbon monoxide liberated from CO-releasing molecule (CO-RM)
Ahanger, A. A., Prawez, S., Kumar, D., Prasad, R., Amarpal, Tandan, S. K., & Kumar, D. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0653-7 · Cited by 49
“CO-RM-liberated CO has demonstrated inhibitory effects on myocardial ischemia–reperfusion damage (Clark et al. 2003; Guo et al. 2004); inflammatory response in LPSstimulated macrophages ( Sawle et al. 2005 ) and expression of CD11b in platelet-activating factor activated polymorphonuclear cells (Urquhart et al. 2007).”
BackgroundGómez-Lomelí, P., Bravo‐Cuéllar, A., Hernández‐Flores, G., Jave‐Suárez, L. F., Aguilar‐Lemarroy, A., Lerma-Díaz, J. M., Domínguez-Rodríguez, J. R., Sánchez-Reyes, K., & Ortiz‐Lazareno, P. C. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0100-1 · Cited by 50
“Similarly, the use the metabolites induced by the action of HO-1 on a heme group, such as CO, ferritin, or bilirubin alone or in combination, induces a decrease in the production of TNF-α, IL-1, IL-6, and IFN-γ, and instead promotes IL-10 production [45,46].”
BackgroundVersatile Applications of Metallopolymers
Götz, S., Zechel, S., Hager, M. D., Newkome, G. R., & Schubert, U. S. (2021) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2021.101428 · Cited by 51
Advances in local drug delivery technologies for improved rheumatoid arthritis therapy
An, X., Yang, J., Cui, X., Zhao, J., Jiang, C., Tang, M., Dong, Y., Lin, L., Li, H., & Wang, F. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115325 · Cited by 53
Babu, D., Leclercq, G., Motterlini, R., & Lefebvre, R. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00031 · Cited by 46
Jesse, H. E., Nye, T. L., McLean, S., Green, J. D., Mann, B. E., & Poole, R. K. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.04.019 · Cited by 46
Bikiel, D. E., Solveyra, E. G., Salvo, F. D., Milagre, H. M. S., Eberlin, M. N., Corrêa, R. S., Ellena, J., Estrin, D. A., & Doctorovich, F. A. (2011) · Inorganic Chemistry · doi:10.1021/ic102038v · Cited by 43
Zimmermann, A., Leffler, C. W., Tcheranova, D., Fedinec, A. L., & Parfenova, H. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00354.2007 · Cited by 45
Park, P., Kim, H. S., Jin, X. Y., Jin, F., Hur, J., Ko, G., & Sohn, D. H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.12.034 · Cited by 45
“In support of our findings, and contrast to the notion that HO-1 negatively regulates iNOS expression, Sawle et al. (2005), reported that treatment of macrophages with CO, a by-product of heme degradation by HO-1, inhibited LPS-induced nitrite production without affecting iNOS protein expression.”
ResultKang, I.-S., Kim, R. I., & Kim, C. (2021) · Cells · doi:10.3390/cells10123444 · Cited by 45
Kung, C.-W., Lee, Y., Cheng, P., Peng, Y., & Yen, M. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.01.006 · Cited by 41
“HO-1-mediated CO and biliverdin suppress transcriptional iNOS expression and TNF-a production in LPS-stimulated macrophages [15, 34].”
BackgroundLee, D., Jeong, G., Li, B., Lee, S. U., Oh, H., & Kim, Y. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10219fp · Cited by 43
Gonzalez, J., Pedroni, S. M. A., & Girardi, G. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau019 · Cited by 46
“It has been shown that macrophages exposed to CO show a suppressed inflammatory response in response to LPS (Sawle et al., 2005).”
BackgroundIron indenyl carbonyl compounds: CO-releasing molecules
Hewison, L., Crook, S. H., Johnson, T. R., Mann, B. E., Adams, H., Plant, S. E., Sawle, P., & Motterlini, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00203h · Cited by 42
Supramolecular Carbon Monoxide‐Releasing Peptide Hydrogel Patch
Kim, I., Han, E. H., Bang, W., Ryu, J., Min, J., Nam, H. C., Park, W. H., Chung, Y., & Lee, E. J. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201803051 · Cited by 46
Pol, O. (2020) · Medicinal Research Reviews · doi:10.1002/med.21726 · Cited by 44
Tailoring gas-releasing nanoplatforms for wound treatment: An emerging approach
Wang, Z., Rong, F., Zhao, L., Li, W., Kaur, K., & Wang, Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.139297 · Cited by 50
Metal-based carbon monoxide releasing molecules with promising cytotoxic properties
Mansour, A. M., Khaled, R. M., Ferraro, G., Shehab, O. R., & Merlino, A. (2024) · Dalton Transactions · doi:10.1039/d4dt00087k · Cited by 46
Carbon Monoxide Attenuates Dextran Sulfate Sodium-Induced Colitis via Inhibition of GSK-3βSignaling
Uddin, M. J., Jeong, S., Zheng, M., Chen, Y., Cho, G. J., Chung, H., & Joe, Y. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/210563 · Cited by 47
“Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2013, Article ID 210563, 9 pages http://dx.doi.org/10.1155/2013/210563”
BackgroundInfluentialBabu, D., Leclercq, G., Goossens, V., Remijsen, Q., Vandenabeele, P., Motterlini, R., & Lefebvre, R. A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.07.007 · Cited by 42
Penicillinolide A: A New Anti-Inflammatory Metabolite from the Marine Fungus Penicillium sp. SF-5292
Lee, D., Ko, W., Quang, T. H., Kim, K.-S., Sohn, J., Jang, J., Ahn, J. C., Kim, Y., & Oh, H. (2013) · Marine Drugs · doi:10.3390/md11114510 · Cited by 43
Banihani, M., Greenstein, D., Mann, B. E., Green, C. J., & Motterlini, R. (2006) · PubMed · Cited by 40
Lin, C., Hsiao, L., Cho, R., & Yang, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133157 · Cited by 41
“CORM-2 mediates the Nox-dependent ROS generation, leading to HO-1 expression [8,9,24].”
BackgroundSmith, H. K., Mann, B. E., Motterlini, R., & Poole, R. K. (2011) · IUBMB Life · doi:10.1002/iub.476 · Cited by 39
“85 mM final concentration) in the defined medium, as N-acetylcysteine (a thiol donor) as well as cysteine and glutathione have been shown to abrogate the effects of CORM-3 in experiments with macrophages (35) and P.”
BackgroundDong, D., Chen, C. Q., Huang, W., Chen, Y., Zhang, X., Li, Z., Li, Y., & Yang, B. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.042 · Cited by 38
Magierowska, K., Magierowski, M., Surmiak, M., Adamski, J., Mazur-Biały, A. I., Pajdo, R., Śliwowski, Z., Kwiecień, S., & Brzozowski, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040442 · Cited by 39
“[17,47] who findings are partially in line with our observations.”
ResultCarbon monoxide decreases the level of iNOS protein and active dimer in IL-1β-stimulated hepatocytes
Kim, H. S., Loughran, P., & Billiar, T. R. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.02.002 · Cited by 39
Tsoyi, K., Ha, Y. M., Kim, Y. M., Lee, Y. S., Kim, H. J., Kim, H. J., Seo, H. G., Lee, J. H., & Chang, K. C. (2009) · Inflammation · doi:10.1007/s10753-009-9144-0 · Cited by 38
“Previous report is different from ours in that CORM-3 significantly reduced NO, but not protein levels of iNOS in LPS-stimulated RAW 264.7 cells [ 19 ].”
ResultInfluentialCarbon Monoxide in Biology and Microbiology: Surprising Roles for the “Detroit Perfume”
Davidge, K. S., Motterlini, R., Mann, B. E., Wilson, J. L., & Poole, R. K. (2009) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(09)05603-3 · Cited by 43
Park, H.-J., Han, E. S., Park, D. K., Lee, C., & Lee, K. W. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2010.1131 · Cited by 41
Photoactivated [Mn(CO)3Br(μ-bpcpd)]2 induces apoptosis in cancer cells via intrinsic pathway
Vidhyapriya, P., Divya, D., Bala, M., & Sakthivel, N. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.08.021 · Cited by 36
He, J., Han, S., Li, X., Wang, Q., Cui, Y., Chen, Y., Gao, H., Huang, L., & Yang, S. (2019) · Molecules · doi:10.3390/molecules24244502 · Cited by 40
Pietro, C. D., Öz, H. H., Murray, T. S., & Bruscia, E. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01059 · Cited by 37
“Murine (Sawle et al., 2005) and human (Chhikara et al., 2009) MFs are particularly responsive to CO treatment, July 2020 | Volume 11 | Article 1059 which attenuates the inflammatory response to LPS (Sawle et al., 2005).”
BackgroundMotterlini, R., Sawle, P., Hammad, J., Mann, B. E., Johnson, T. R., Green, C. J., & Foresti, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.12.001 · Cited by 37
Nakao, A., Faleo, G., Nalesnik, M. A., Neto, J. S., Kohmoto, J., & Murase, N. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90728.2008 · Cited by 36
“The results may indicate that endogenous HO-1 expression associates with renal graft injury, and effective treatments appear to inhibit HO-1 upregulation.”
BackgroundInfluential
Metadata
- Authors
- Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R.
- Affiliations
- Northwick Park Institute for Medical Research (GB)
- University of Sheffield (GB)
- Corresponding author
- Motterlini, Roberto
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-07
- Volume
- 145
- Issue
- 6
- Pages
- 800-810
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1576195
- OpenAlex
- W2094470927
- Cited by
- 391
- References
- 36
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 7 · 2022: 16 · 2021: 22 · 2020: 16 · 2019: 10 · 2018: 18 · 2017: 14 · 2016: 16 · 2015: 20 · 2014: 21 · 2013: 24 · 2012: 25
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation
- Dunhill Medical Trust
- Engineering and Physical Sciences Research Council (GR/S30924/01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- carbon monoxide-releasing molecules, CORM-2, CORM-3, carbon monoxide, heme oxygenase-1, lipopolysaccharide, macrophages, RAW 264.7 macrophages, nitric oxide, inducible nitric oxide synthase, TNF-α, inflammation, anti-inflammatory activity, N-acetylcysteine
- MeSH terms
- Animals, Carbon Monoxide, Cell Line, Cell Survival, Glutathione, Heme Oxygenase (Decyclizing), Inflammation, Lipopolysaccharides, Macrophages, Membrane Proteins, Nitrites, Organometallic Compounds, Tumor Necrosis Factor-alpha, Nitric Oxide Synthase, Mice, Heme Oxygenase-1, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.